High-Precision Single-Cell microRNA Therapy by a Functional Nanopipette with Sensitive Photoelectrochemical Feedback

This work proposes the concept of single-cell microRNA (miR) therapy and proof-of-concept by engineering a nanopipette for high-precision miR-21-targeted therapy in a single HeLa cell with sensitive photoelectrochemical (PEC) feedback. Targeting the representative oncogenic miR-21, the as-functionalized nanopipette permits direct intracellular drug administration with precisely controllable dosages, and the corresponding therapeutic effects can be sensitively transduced by a PEC sensing interface that selectively responds to the indicator level of cytosolic caspase-3. The experimental results reveal that injection of ca. 4.4 x 10-20 mol miR-21 inhibitor, i.e., 26488 copies, can cause the obvious therapeutic action in the targeted cell. This work features a solution to obtain the accurate knowledge of how a certain miR-drug with specific dosages treats the cells and thus provides an insight into futuristic high-precision clinical miR therapy using personalized medicine, provided that the prerequisite single-cell experiments are courses of personalized customization. The concept of high-precision single-cell microRNA therapy is proposed and devised by a functional nanopipette, which allows precise miR-21 inhibitor delivery to induce cell apoptosis and responds selectively to caspase-3 of a sensitive photoelectrochemical feedback. It can reveal what the precise drug amount can cause the effective therapeutic action.image

Automated summary

This work proposes and verifies the concept of single-cell miR therapy, and demonstrates high-precision miR-21 targeted therapy using a nanopipette. The experimental results show that the therapeutic effects can be achieved through direct intracellular drug administration and selective response of a PEC sensing interface. This work provides important insights into high-precision clinical miR therapy in personalized medicine.